According to VYNE Therapeutics's latest financial reports the company's current earnings (TTM) are -A$46.26 M. In 2023 the company made an earning of -A$43.89 M an increase over its 2022 earnings that were of -A$51.09 M.The earnings displayed on this page is the company's Pretax Income.